KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist (Q34133179)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist (English)

1 reference

Europe PubMed Central

31 July 2017

author name string

Mayumi Saki

1

1 reference

Europe PubMed Central

31 July 2017

Hiroshi Tsumuki

2

1 reference

Europe PubMed Central

31 July 2017

Hiromi Nonaka

3

1 reference

Europe PubMed Central

31 July 2017

Junichi Shimada

4

1 reference

Europe PubMed Central

31 July 2017

Michio Ichimura

5

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

31 July 2017

European Journal of Pharmacology

1 reference

Europe PubMed Central

31 July 2017

444

1 reference

Europe PubMed Central

31 July 2017

3

1 reference

Europe PubMed Central

31 July 2017

133-141

1 reference

Europe PubMed Central

31 July 2017

Some quantitative uses of drug antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

A(3) adenosine receptor ligands: history and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

The effects of saponin on the binding and functional properties of the human adenosine A1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Molecular cloning and expression of the gene for a human D1 dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Cloning of the cDNA and gene for a human D2 dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Binding characteristics of 3H-prazosin to rat brain α-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

[3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

The binding of [3H]mepyramine to histamine H1 receptors in guinea-pig brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Pharmacological characterization of novel A3 adenosine receptor-selective antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Molecular cloning of adenosine A1 and A2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

G-protein alpha-subunit expression, myristoylation, and membrane association in COS cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Adenosine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Molecular cloning and characterization of the human A3 adenosine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc epsilon RI

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Interaction of mianserin, amitriptyline and haloperidol with guinea pig cerebral histamine H2 receptors studied with [125I]iodoaminopotentidine

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Adenosine A3 receptor stimulation and cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Adenosine A3 receptor expression and function in eosinophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901662-X

7 January 2021

Identifiers

10.1016/S0014-2999(02)01662-X

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34133179&oldid=1540450924"